CCMH
GEVA

Cornerstone Capital Management Holdings’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,400
Closed -$234K – 1545
2015
Q1 		$234K Buy
2,400
+300
+14% +$31.8K ﹤0.01% 1155
2014
Q4 		$195K Buy
2,100
+700
+50% +$55.2K ﹤0.01% 1095
2014
Q3 		$96K Buy
+1,400
New +$100K ﹤0.01% 1178

Cornerstone Capital Management Holdings's GEVA Position: Q2 2015 in Review

Cornerstone Capital Management Holdings sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 2,400 shares — an estimated $234K sold.

Cornerstone Capital Management Holdings first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $234K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Cornerstone Capital Management Holdings reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 2,400 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $234K.
  • Cornerstone Capital Management Holdings first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Cornerstone Capital Management Holdings's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $234K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2015, filed 11 Aug 2015.